Literature DB >> 11182286

Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.

V W Yiu1, T Kovithavongs, L F McGonigle, P Ferreira.   

Abstract

A 6-year-old female diagnosed with idiopathic opsoclonus-myoclonus syndrome at 22 months of age who failed to respond to treatment with adrenocorticotropic hormone (ACTH), IV gammaglobulin (IVIG), and azathioprine is presented. Because of marked and progressive deterioration in motor function and speech, this patient received a course of plasmapheresis with concomitant steroids and azathioprine. Within 1 week, marked improvements in motor function were noted. Eighteen months later, the patient ambulates, walks without support, and attends a regular school in the appropriate grade level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182286     DOI: 10.1016/s0887-8994(00)00227-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Therapeutic total plasma exchange in a child with neuroblastoma-related anti-Hu syndrome.

Authors:  Dannis G van Vuurden; Frans B Plötz; Miranda de Jong; Arend Bokenkamp; Joanna A E van Wijk
Journal:  Pediatr Nephrol       Date:  2005-08-24       Impact factor: 3.714

2.  West nile virus encephalitis induced opsoclonus-myoclonus syndrome.

Authors:  Chad J Cooper; Sarmad Said
Journal:  Neurol Int       Date:  2014-04-22

Review 3.  Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges.

Authors:  Abdulhafeez M Khair
Journal:  Neurol Res Int       Date:  2016-04-28

4.  Opsoclonus myoclonus ataxia syndrome due to falciparum malaria in two Indian children.

Authors:  Kallol Bose; Sudip Saha; Md Rahiul Islam; Chayan Chakraborty; Mustakim Laskar
Journal:  Indian J Ophthalmol       Date:  2016-11       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.